Long-term results of a phase II trial of high-dose radiotherapy (60 Gy) and UFT/l-leucovorin in patients with non-resectable locally advanced rectal cancer (LARC)

By Vestermark Lene   Jacobsen Anders   Qvortrup Camilla   Hansen Flemming   Bisgaard Claus   Baatrup Gunnar   Rasmussen Peter   Pfeiffer Per  

Acta Oncologica, Vol. 47, Iss. 3, 2007-12 ,pp. : 428-433

Informa Healthcare

Access to resources Recommend Favorite

High-dose radiotherapy and concurrent UFT plus l-leucovorin in locally advanced rectal cancer: A phase I trial

By Pfeiffer Per  

Acta Oncologica, Vol. 44, Iss. 3, 2005-05 ,pp. : 224-229

Informa Healthcare

Access to resources Recommend Favorite

Phase I study of a weekly schedule of a fixed dose of cisplatin and escalating doses of paclitaxel in patients with advanced oesophageal cancer

By Polee M.B.   Verweij J.   Siersema P.D.   Tilanus H.W.   Splinter T.A.W.   Stoter G.   Van der Gaast A.  

European Journal of Cancer, Vol. 38, Iss. 11, 2002-07 ,pp. : 1495-1500

Elsevier

Access to resources Recommend Favorite

Neoadjuvant chemoradiotherapy with or without panitumumab in patients with wild-type KRAS , locally advanced rectal cancer (LARC): a randomized, multicenter, phase II trial SAKK 41/07

By Helbling D.   Bodoky G.   Gautschi O.   Sun H.   Bosman F.   Gloor B.   Burkhard R.   Winterhalder R.   Madlung A.   Rauch D.   Saletti P.   Widmer L.   Borner M.   Baertschi D.   Yan P.   Benhattar J.   Leibundgut E. O.   Bougel S.   Koeberle D.  

Annals of Oncology, Vol. 24, Iss. 3, 2013-03 ,pp. : 718-725

Oxford University Press

Access to resources Recommend Favorite

Multicenter phase II clinical trial of preoperative capecitabine with concurrent radiotherapy in patients with locally advanced rectal cancer

By las Heras Manuel  

Clinical and Translational Oncology, Vol. 15, Iss. 4, 2013-04 ,pp. : 294-299

Springer Publishing Company

Access to resources Recommend Favorite